COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study.


Journal

The Lancet. Rheumatology
ISSN: 2665-9913
Titre abrégé: Lancet Rheumatol
Pays: England
ID NLM: 101765308

Informations de publication

Date de publication:
Jun 2021
Historique:
pubmed: 1 4 2021
medline: 1 4 2021
entrez: 31 3 2021
Statut: ppublish

Résumé

Various observations have suggested that the course of COVID-19 might be less favourable in patients with inflammatory rheumatic and musculoskeletal diseases receiving rituximab compared with those not receiving rituximab. We aimed to investigate whether treatment with rituximab is associated with severe COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases. In this cohort study, we analysed data from the French RMD COVID-19 cohort, which included patients aged 18 years or older with inflammatory rheumatic and musculoskeletal diseases and highly suspected or confirmed COVID-19. The primary endpoint was the severity of COVID-19 in patients treated with rituximab (rituximab group) compared with patients who did not receive rituximab (no rituximab group). Severe disease was defined as that requiring admission to an intensive care unit or leading to death. Secondary objectives were to analyse deaths and duration of hospital stay. The inverse probability of treatment weighting propensity score method was used to adjust for potential confounding factors (age, sex, arterial hypertension, diabetes, smoking status, body-mass index, interstitial lung disease, cardiovascular diseases, cancer, corticosteroid use, chronic renal failure, and the underlying disease [rheumatoid arthritis Between April 15, 2020, and Nov 20, 2020, data were collected for 1090 patients (mean age 55·2 years [SD 16·4]); 734 (67%) were female and 356 (33%) were male. Of the 1090 patients, 137 (13%) developed severe COVID-19 and 89 (8%) died. After adjusting for potential confounding factors, severe disease was observed more frequently (effect size 3·26, 95% CI 1·66-6·40, p=0·0006) and the duration of hospital stay was markedly longer (0·62, 0·46-0·85, p=0·0024) in the 63 patients in the rituximab group than in the 1027 patients in the no rituximab group. 13 (21%) of 63 patients in the rituximab group died compared with 76 (7%) of 1027 patients in the no rituximab group, but the adjusted risk of death was not significantly increased in the rituximab group (effect size 1·32, 95% CI 0·55-3·19, p=0·53). Rituximab therapy is associated with more severe COVID-19. Rituximab will have to be prescribed with particular caution in patients with inflammatory rheumatic and musculoskeletal diseases. None.

Sections du résumé

BACKGROUND BACKGROUND
Various observations have suggested that the course of COVID-19 might be less favourable in patients with inflammatory rheumatic and musculoskeletal diseases receiving rituximab compared with those not receiving rituximab. We aimed to investigate whether treatment with rituximab is associated with severe COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases.
METHODS METHODS
In this cohort study, we analysed data from the French RMD COVID-19 cohort, which included patients aged 18 years or older with inflammatory rheumatic and musculoskeletal diseases and highly suspected or confirmed COVID-19. The primary endpoint was the severity of COVID-19 in patients treated with rituximab (rituximab group) compared with patients who did not receive rituximab (no rituximab group). Severe disease was defined as that requiring admission to an intensive care unit or leading to death. Secondary objectives were to analyse deaths and duration of hospital stay. The inverse probability of treatment weighting propensity score method was used to adjust for potential confounding factors (age, sex, arterial hypertension, diabetes, smoking status, body-mass index, interstitial lung disease, cardiovascular diseases, cancer, corticosteroid use, chronic renal failure, and the underlying disease [rheumatoid arthritis
FINDINGS RESULTS
Between April 15, 2020, and Nov 20, 2020, data were collected for 1090 patients (mean age 55·2 years [SD 16·4]); 734 (67%) were female and 356 (33%) were male. Of the 1090 patients, 137 (13%) developed severe COVID-19 and 89 (8%) died. After adjusting for potential confounding factors, severe disease was observed more frequently (effect size 3·26, 95% CI 1·66-6·40, p=0·0006) and the duration of hospital stay was markedly longer (0·62, 0·46-0·85, p=0·0024) in the 63 patients in the rituximab group than in the 1027 patients in the no rituximab group. 13 (21%) of 63 patients in the rituximab group died compared with 76 (7%) of 1027 patients in the no rituximab group, but the adjusted risk of death was not significantly increased in the rituximab group (effect size 1·32, 95% CI 0·55-3·19, p=0·53).
INTERPRETATION CONCLUSIONS
Rituximab therapy is associated with more severe COVID-19. Rituximab will have to be prescribed with particular caution in patients with inflammatory rheumatic and musculoskeletal diseases.
FUNDING BACKGROUND
None.

Identifiants

pubmed: 33786454
doi: 10.1016/S2665-9913(21)00059-X
pii: S2665-9913(21)00059-X
pmc: PMC7993930
doi:

Banques de données

ClinicalTrials.gov
['NCT04353609']

Types de publication

Journal Article

Langues

eng

Pagination

e419-e426

Investigateurs

Florence Aeschlimann (F)
Christian Agard (C)
Nassim Ait-Abdallah (N)
Jean-David Albert (JD)
Didier Alcais (D)
Jean-Sébastien Allain (JS)
Yannick Allanore (Y)
Blanca Amador-Borreiro (B)
Zahir Amoura (Z)
Emma Andre (E)
Anaïs Arbault (A)
Jean-Benoît Arlet (JB)
Laurent Arnaud (L)
Denis Arniaud (D)
Herliette Arty-Hue (H)
Lucie Atlan (L)
Alexandra Audemard-Verger (A)
Christine Audoin-Pajot (C)
Victor Audren (V)
Maxime Bach-Bunner (M)
Hélène Bacquet-Deschryver (H)
Brigitte Bader-Meunier (B)
Nathalie Balandraud (N)
Jean-Charles Balblanc (JC)
Stéphane Bally (S)
Frédéric Banal (F)
Pierre Barbery (P)
Thomas Barnetche (T)
Audre Barrelet (A)
André Basch (A)
Vincent Baumier (V)
Guillaume Bayer (G)
Sophie Bayle (S)
Catherine Beauvais (C)
Rudie Beinat (R)
Véronique Belin (V)
Rakiba Belkhir (R)
Ruben Benainous (R)
Alexandre Belot (A)
Mohammed Benammar (M)
Mathilde Benhamou (M)
Ygal Benhamou (Y)
Ahmed Benmansour (A)
Pascal Bennet (P)
Brigitte Bernoux-Manat (B)
Elise Berthet (E)
Emilie Berthoux (E)
Ewa Bertolini (E)
Adrien Bigot (A)
Aurélia Bisson-Vaivre (A)
Gilles Blaison (G)
Gilles Bolla (G)
Olivier Bonidan (O)
Christine Bonnet (C)
Raphaël Borie (R)
Marie Bossert (M)
Laurence Boudou (L)
Françoise Bouhour (F)
Kévin Bouiller (K)
Bastien Bouldoires (B)
Karima Boussoualim (K)
Eric Bouvard (E)
Regine Brondino (R)
Pierre Buchlin (P)
Laurence Cabantous (L)
Patrice Cacoub (P)
Simon Cadiou (S)
Maurizio Carteni (M)
Aurélia Carbasse (A)
Brice Castel (B)
Pascal Cathebras (P)
Hervé Caumont (H)
Annalisa Celant (A)
Benjamin Chaigne (B)
Benoît Chaillous (B)
Romuald Champy (R)
Agnès Charcot (A)
Pierre Charles (P)
Isabelle Charlot-Lambrecht (I)
Caroline Charpin (C)
Emmanuel Chatelus (E)
Bernard Chaudier (B)
Pascale Chertok (P)
Xavier Chevalier (X)
Maxime Chevreau (M)
Emilie Chotard (E)
Delphine Chu Miow Lin (D)
Gaëlle Clavel (G)
Cyril Clavel-Osorio (C)
Fleur Cohen (F)
Gregory Cohen (G)
Marie-Eve Colette-Cedoz (ME)
Nived Collercandy (N)
Antoine Colombey (A)
Chloé Comarmond (C)
Bernard Combe (B)
Céline Comparon (C)
Elodie Constant (E)
Pascal Coquerelle (P)
Justine Corli (J)
Clémence Corre (C)
Nathalie Costedoat-Chalumeau (N)
Marie Couret (M)
Natacha Courvoisier (N)
Fabienne Coury-Lucas (F)
Cécile Coutarel (C)
Fabrice Coutier (F)
Richard Damade (R)
Laurence Daver-Malaterre (L)
Sarahe Dehimat (S)
Michel Delahousse (M)
Emilie Barrois-Delattre (E)
Delphine Denarie (D)
Camille Deprouw (C)
Emanuelle Dernis (E)
Alban Deroux (A)
Renaud Desbarbieux (R)
Elise Descamps (E)
Chantal Deslandre (C)
Marie Desmurs (M)
Jacques Despaux (J)
Marie Desplats (M)
Frédérick Detree (F)
Valérie Devauchelle-Pensec (V)
Robin Dhote (R)
Philippe Dieude (P)
Yannick Dieudonne (Y)
Elisabeth Diot (E)
Guillaume Direz (G)
Djamal-Dine Djeddi (DD)
Sarah Douvier (S)
Béatrice Drouet (B)
Elodie Drumez (E)
Catherine Duc (C)
Angélique Ducornet (A)
Carine Dufauret-Lombard (C)
Alain Duhamel (A)
Cécile Dumaine (C)
Anne-Elisabeth Dumel (AE)
Chantal Dumoulin-Richez (C)
Agnès Duquesne (A)
Géraldine Durand (G)
Mariane Durandin-Truffinet (M)
Pierre-Marie Duret (PM)
Maïka Duval (M)
Mikaël Ebbo (M)
Esther Ebstein (E)
Andra Economu-Dubosc (A)
Stéphanie Emilie (S)
Romain Euvrard (R)
Philippe Evon (P)
Sylvie Fabre (S)
Dorothée Fagedet (D)
Meryem Farhat (M)
Marion Fauconier (M)
Jacques Fechtenbaum (J)
Renaud Felten (R)
Fanny Fernandes (F)
Nicole Ferreira-Maldent (N)
Elodie Feurer (E)
Amandine Fichet (A)
Françoise Flaisler (F)
Nans Florens (N)
Violaine Foltz (V)
Elisabeth Fontanges (E)
Jennifer Foret (J)
Anne-Claire Fougerousse (AC)
Anne Fouque-Aubert (A)
Catherine Foutrier-Morello (C)
Hélène Francois-Pradier (H)
Léa Frantzen (L)
Pierre Fritz (P)
Antoine Froissart (A)
Jean Fulpin (J)
Piera Fuzibet (P)
Francis Gaches (F)
Laurence Gagneux-Lemoussu (L)
Mélanie Penhoat-Gahier (M)
Joris Galland (J)
Frédérique Gandjbakhch (F)
Nicole Garnier (N)
Thomas Garraud (T)
Jean-François Garrot (JF)
Romain Gastaldi (R)
Véronique Gaud-Listrat (V)
Maud Gauthier-Prieur (M)
Dana Georgescu (D)
Nathalie Gerard (N)
Elisabeth Gervais (E)
Christelle Gibert (C)
Eric Gibert (E)
Ghislaine Gill (G)
Jérôme Gillard (J)
Mélanie Gilson (M)
Pauline Gimonnet (P)
Jeanine-Sophie Giraudet-Le Quintrec (JS)
Aude Giraud-Morelet (A)
Baptiste Glace (B)
Camille Glanowski (C)
Bertrand Godeau (B)
Bruno Gombert (B)
Camille Gonnet-Gracia (C)
Tiphaine Goulenok (T)
Philippe Goupille (P)
Olivier Gourmelen (O)
Sophie Govindaraju-Audouard (S)
Franck Grados (F)
Martine Grall-Lerosey (M)
Bruno Grardel (B)
Anne Grasland (A)
Gilles Grateau (G)
Monica Groza (M)
Constance Guillaud (C)
Séverine Guillaume (S)
Caroline Guillibert (C)
Xavier Guillot (X)
Philippe Guilpain (P)
Aline Gury (A)
Marie-Hélène Guyot (MH)
Cécile Hacquard-Bouder (C)
Marie-Noelle Havard (MN)
Jean-Pierre Hellier (JP)
Pascal Hennequin (P)
Basile Henriot (B)
Julien Henry (J)
Véronique Hentgen (V)
Marion Hermet (M)
Muriel Herasse (M)
Julie Hernandez (J)
Miguel Hie (M)
Pascal Hilliquin (P)
Olivier Hinschberger (O)
Ambre Hittinger-Roux (A)
Jan Holubar (J)
Christophe Hudry (C)
Serge Huguenel (S)
Clara Jaccard (C)
Jean-Michel Jacquemier (JM)
Bénédicte Jamard (B)
Catherine Jan (C)
Sylvie Jean (S)
Mathieu Jouvray (M)
Pierre-Antoine Juge (PA)
Laurent Juillard (L)
Denis Jullien (D)
Anna Kabala (A)
Abdelkrim Kabchou (A)
Ludovic Karkowski (L)
Françoise Karman (F)
Farid Kemiche (F)
Jérémy Keraen (J)
Pierre Kieffer (P)
Isabelle Kone-Paut (I)
Abdeldajallil Koreichi (A)
Marie Kostine (M)
Sylvain La Batide Alanore (S)
Pierre Lafforgue (P)
Sophie Lahalle (S)
Marc Lambert (M)
Isabelle Lambrecht (I)
Sylvain Lanot (S)
Aurélia Lanteri (A)
Jean-Paul Larbre (JP)
Augustin Latourte (A)
Christian Lavigne (C)
Sophie Le Guen Guegan (S)
Guillaume Le Guenno (G)
Diane Leguy (D)
Agnès Lebrun (A)
Emmanuel Ledoult (E)
Nathalie Legoupil (N)
Erick Legrand (E)
Charlotte Lejeune (C)
Olivier Leloire (O)
Christophe Leroux (C)
Rémi Leroy (R)
Marie Leroy-Gouix (M)
Tifenn Leturcq (T)
Amélie Leurs (A)
Céline Leveque-Michaud (C)
François-Xavier Limbach (FX)
Frédéric Liote (F)
Anne Lohse (A)
Pierre Lozac'h (P)
Virginie Lucas (V)
Aurélie Madelon (A)
Nadine Magy-Bertrand (N)
Matthieu Mahevas (M)
Hélène Maillard (H)
Thibault Maillet (T)
Sandrine Malochet-Guinamand (S)
Quentin Mangon (Q)
Sylvie Marchou-Lopez (S)
Nathalie Margarit (N)
Thierry Marhadour (T)
Xavier Mariette (X)
Claire Martin (C)
Alexis Mathian (A)
François Maurier (F)
Frédéric Maury (F)
Betty Mazet-Guillaume (B)
Arnaud Mazouyez (A)
Hassan Mazyad (H)
Nadia Mehsen-Cetre (N)
Ulrich Meinzer (U)
Isabelle Melki (I)
Laurent Messer (L)
Corinne Miceli (C)
Martin Michaud (M)
Catherine Michel (C)
Matthias Michel (M)
Mathilde Michon (M)
Anne-Marie Milesi-Lecat (AM)
Anna Molto (A)
Marie Moly (M)
Olivier Moranne (O)
Gautier Morel (G)
Hugo Morel (H)
Jacques Morel (J)
Franck Morin (F)
Laurence Moulinier (L)
Guillaume Moulis (G)
Bertrand Moura (B)
Minh Nguyen (M)
Sabine Nicolas-Vullierme (S)
Hubert Nielly (H)
Gaétane Nocturne (G)
Aurore Nottez (A)
Henri-Olivier Ollagnon (HO)
Isabelle Pacaud-Vitoux (I)
Anne Pagnier (A)
Caroline Paris (C)
Antoine Parrot (A)
Tristan Pascart (T)
Yasmina Pascaud-Mansour (Y)
Lætitia Paulin (L)
Stephan Pavy (S)
Laurent Perard (L)
Yves-Marie Pers (YM)
Micheline Pha (M)
Maud Pichon (M)
Audrey Pierreisnard (A)
Gabrielle Pizana (G)
Sylvaine Poignant (S)
Elsa Poix (E)
Agnès Portier (A)
Antoine Poulet (A)
Samira Plassard (S)
Grégory Pugnet (G)
Déborah Puyraimond-Zemmour (D)
Pierre Quartier-Dit-Maire (P)
Marion Quenet (M)
Viviane Queyrel (V)
Loïc Raffray (L)
Philippe Remy (P)
Myriam Renard (M)
Jessica Rene (J)
Sabine Revuz (S)
Bénédicte Rey (B)
Gaëlle Richard-Colmant (G)
Etienne Riviere (E)
Sébastien Riviere (S)
Sophie Robin (S)
Julien Rohmer (J)
Isabelle Roitg (I)
Mélanie Romier (M)
Michel Rolland (M)
Mélanie Roriz (M)
Carole Rosenberg (C)
Linda Rossi (L)
Olivier Roth (O)
Sid-Ahmed Rouidi (SA)
Mathilde Roumier (M)
Mickaël Rousiere (M)
Clémentine Rousselin (C)
Bénédicte Rouviere (B)
Christian Roux (C)
Fabienne Roux (F)
Marielle Roux (M)
Nicolas Roux (N)
Diane Rouzaud (D)
Sylvie Rozenberg (S)
Isabelle Sacco (I)
Fatiha Sadji (F)
Laurent Sailler (L)
Carine Salliot (C)
Jean-Hugues Salmon (JH)
Alain Saraux (A)
Jean Schmidt (J)
Julie Seguier (J)
Jérémie Sellam (J)
Eric Senbel (E)
Thomas Sene (T)
Patricia Senet (P)
Pascal Seve (P)
Aurélie Sicaud (A)
Perrine Smets (P)
Vincent Sobanski (V)
Christelle Sordet (C)
Elisabeth Sornay-Rendu (E)
Odile Souchaud-Debouverie (O)
Lætitia Sparsa (L)
Lionel Spielmann (L)
Sarah Steib (S)
Chloé Stavris (C)
Catherine Straus (C)
Victor Strotz (V)
Paulina Szafors (P)
Séverine Taffignon-Clave (S)
Justine Simoens (J)
Claire Theillac (C)
Nora Tenenbaum (N)
Benoît Thomachot (B)
Nathalie Tieulie (N)
Soizic Tiriau (S)
Alice Tison (A)
Eric Toussirot (E)
Ludovic Trefond (L)
Sophie Trijau (S)
Sébastien Trouillier (S)
Anne-Priscille Trouvin (AP)
Marie-Elise Truchetet (ME)
Marc Ulrich (M)
Jacques Vaquier (J)
Eric Veillard (E)
Laurent Veillon (L)
Eric Veillard (E)
Laurent Veillon (L)
Guillaume Vial (G)
Jean-François Viallard (JF)
Judith Victor (J)
Claire Vidon (C)
Mathias Vidon (M)
Camille Vigne (C)
Alexandre Virone (A)
Ursula Warzocha (U)
Daniel Wendling (D)
Claude Werle (C)
Cécile Wibaux (C)
Alexandra Willems (A)
Michel Wisniewski (M)
Juliette Woessner (J)
Bernadette Xerri-Campano (B)

Informations de copyright

© 2021 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

We declare no competing interests.

Références

Ann Rheum Dis. 2020 Dec 2;:
pubmed: 33268442
Arthritis Rheumatol. 2021 Feb;73(2):e1-e12
pubmed: 33277981
Stat Med. 2009 Nov 10;28(25):3083-107
pubmed: 19757444
Ann Rheum Dis. 2020 Jun 5;:
pubmed: 32503849
Br J Haematol. 2020 Jul;190(2):185-188
pubmed: 32557623
Clin Lymphoma Myeloma Leuk. 2020 Nov;20(11):774-776
pubmed: 32933879
Nature. 2020 May;581(7809):465-469
pubmed: 32235945
Ann Rheum Dis. 2020 Jun 26;:
pubmed: 32591357
Science. 2020 Sep 4;369(6508):
pubmed: 32669297
BMC Med Res Methodol. 2011 Oct 26;11:144
pubmed: 22029846
Ann Rheum Dis. 2021 Jan;80(1):e10
pubmed: 32312768
Stat Med. 2015 Dec 10;34(28):3661-79
pubmed: 26238958
Lancet Rheumatol. 2020 Oct;2(10):e589-e590
pubmed: 33521659
Pharm Stat. 2011 Mar-Apr;10(2):150-61
pubmed: 20925139
Front Oncol. 2020 Sep 02;10:1578
pubmed: 32984017
Arthritis Rheumatol. 2020 Sep;72(9):1581-1582
pubmed: 32458534
Ann Rheum Dis. 2020 Jul;79(7):851-858
pubmed: 32503854
Ann Rheum Dis. 2020 Sep;79(9):1156-1162
pubmed: 32457048
Ann Rheum Dis. 2020 Aug 4;:
pubmed: 32753417
Ann Rheum Dis. 2021 Jan 27;:
pubmed: 33504483
Ann Rheum Dis. 2020 May;79(5):667-668
pubmed: 32241793
Lancet Infect Dis. 2020 May;20(5):565-574
pubmed: 32213337
N Engl J Med. 2020 Jul 2;383(1):85-88
pubmed: 32348641
Ann Rheum Dis. 2020 Aug 7;:
pubmed: 32769153
J Rheumatol. 2020 Aug 1;47(8):1296
pubmed: 32335513
Science. 2020 Aug 7;369(6504):718-724
pubmed: 32661059
Semin Arthritis Rheum. 2020 Oct;50(5):1087-1088
pubmed: 32916559

Auteurs

Jérôme Avouac (J)

Université de Paris, Service de Rhumatologie, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, Centre Université de Paris, Paris, France.

Elodie Drumez (E)

ULR 2694-METRICS: Évaluation des Technologies de Santé et des Pratiques Médicales, Université de Lille, CHU Lille, Lille, France.

Eric Hachulla (E)

Université de Lille, INSERM, CHU Lille, Service de Médecine Interne et Immunologie Clinique, Centre de Référence des Maladies Autoimmunes Systémiques Rares Du Nord et Nord-Ouest de France, U1286-INFINITE: Institute for Translational Research in Inflammation, Le Kremlin-Bicêtre, France.

Raphaèle Seror (R)

Université Paris-Saclay, Assistance Publique-Hôpitaux de Paris, Service de Rhumatologie, Centre de Référence des Maladies Autoimmunes Systémiques Rares, Hôpital Bicêtre, INSERM UMR 1184, Le Kremlin-Bicêtre, France.

Sophie Georgin-Lavialle (S)

Sorbonne Université, Service de Médecine Interne, Hôpital Tenon, Assistance Publique-Hôpitaux de Paris, Paris, France.

Soumaya El Mahou (S)

Service de Rhumatologie, Centre Hospitalier de Tourcoing, Tourcoing, France.

Edouard Pertuiset (E)

Service de Rhumatologie, Centre Hospitalier René Dubos, Pontoise, France.

Thao Pham (T)

Service de Rhumatologie, Aix-Marseille Université, Assistance Publique-Hôpitaux de Marseille, Marseille, France.

Hubert Marotte (H)

INSERM 1059, Université de Lyon, Saint-Etienne, France.
Service de Rhumatologie and CIC-1408, CHU de Saint-Etienne, Saint-Etienne, France.
CHU de Saint-Etienne, Saint-Etienne, France.

Amélie Servettaz (A)

Service de Médecine Interne, Maladies Infectieuses et Immunologie Clinique, CHU Reims, Hôpital Robert Debré, Reims, France.

Fanny Domont (F)

Sorbonne Université, Assistance Publique-Hôpitaux de Paris, Groupe Hospitalier Pitié-Salpêtrière, Service de Médecine Interne et Immunologie Clinique, Paris, France.

Pascal Chazerain (P)

Service de Rhumatologie et Médecine Interne, Groupe Hospitalier Diaconesses-croix St-Simon, Paris, France.

Mathilde Devaux (M)

Service de Médecine Interne, CHI Poissy Saint Germain, Poissy, France.

Pascal Claudepierre (P)

EpiDermE, Université Paris Est Créteil, Service de Rhumatologie, Hôpital Henri-Mondor, Assistance Publique-Hôpitaux de Paris, Créteil, France.

Vincent Langlois (V)

Service de Maladies Infectieuses et Médecine Interne, Groupe Hospitalier du Havre, Le Havre, France.

Arsène Mekinian (A)

Sorbonne Université, Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Antoine, Service de Médecine Interne et Inflammation- (DMU i3), Paris, France.

Alexandre Thibault Jacques Maria (ATJ)

Service de Médecine Interne: Maladies Multi-Organiques, CHU Montpellier, Montpellier, France.

Béatrice Banneville (B)

Sorbonne Université, Assistance Publique-Hôpitaux de Paris, Service de Rhumatologie, Hôpital de la Pitié-Salpêtrière, Paris, France.

Bruno Fautrel (B)

Sorbonne Université, Assistance Publique-Hôpitaux de Paris, Service de Rhumatologie, Hôpital de la Pitié-Salpêtrière, Paris, France.

Jacques Pouchot (J)

Hôpital Européen Georges-Pompidou, Médecine Interne, Assistance Publique-Hôpitaux de Paris, Paris, France.

Thierry Thomas (T)

Service de Rhumatologie, Hôpital Nord, CHU de Saint-Etienne, INSERM U1059, Université de Lyon-Université Jean Monnet, Saint Etienne, France.

René-Marc Flipo (RM)

Service de Rhumatologie, Université Lille, CHU Lille, Lille.

Christophe Richez (C)

Service de Rhumatologie, Centre de Référence des Maladies Autoimmunes Systémiques Rares de l'Est et du Sud-Ouest de France, CHU de Bordeaux and UMR-CNRS 5164, Université de Bordeaux, Bordeaux, France.

Classifications MeSH